BIK and breast carcinoma: Previous reports demonstrate that fulvestrant treatment of ERα+ breast cancer cells causes mRNA upregulation of the pro-apoptotic BH3-only family member, BIK, but not other BH3-only factors, such as PUMA33, 34.